Randomized phase III study of intravenous (IV) paclitaxel and cisplatin versus IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): a Gynecologic Oncology Group trial (GOG 172). - Armstrong,D.K.; Bundy,B.N.; Baergen,R.; Lele,S.B.; Copeland,L.J.; Walker,J.; Burger,R. (Proc Am Soc Clin Oncol, 2002)